PanCAN welcomes Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum to the Board of Directors.

The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, ...

As part of our strategic approach to improve outcomes for pancreatic cancer patients, our Scientific and Medical Affairs team conducts independent and collaborative research. We disseminate important ...

A new PanCAN-authored paper uses feedback provided by patients with pancreatic cancer to identify trends in reporting pain.

Guiding the Pancreatic Cancer Community - Pancreatic Cancer Action Network*PanCAN’s Case Managers are not medical or nutritional professionals and are therefore unable to provide medical/nutritional ...

Pancreatic cancer patients who participate in clinical research have better outcomes. Learn more and search our up-to-date clinical trials database.

LOS ANGELES, CALIF. – (July 7, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, proudly announces new appointments and ...

LOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership ...